David Haylock


David Haylock, CEO VivaZome Therapeutics

Roberto Ciboldi


Business Development Manager, Pall Corporation


Exosome - Q&A Session Transcript

Learn More About the iCELLis Bioreactors



The iCELLis bioreactor system is an automated, single-use, fixed-bed bioreactor that provides excellent cell growth conditions for adherent cells.

More Biotech Webinars
Our webinars keep you informed on the latest products and technologies, current industry topics, the latest trends and a range of innovations and solutions to help continuously improve your processes.
January 2022
Gene Therapy Downstream Manufacturing, Scale-up and Best Practices

Biotech | Pall Corporation webinar series

Meet the authors from the ‘Insights on Successful Gene Therapy Manufacturing and Commercialization’ ebook